Abstract | PURPOSE: MATERIALS AND METHODS: The study included 84 children diagnosed with medulloblastoma treated with either passively scattered protons (n = 38) or photons (n = 46). Patients underwent maximal safe resection followed by craniospinal irradiation, posterior fossa and/or tumor bed boost and chemotherapy according to one of 3 multi-institutional trials. Median audiogram follow-up was 56 months for protons and 66 months for photons. RESULTS: Mean cochlear dose (Dmc) was lower in patients treated with protons for both standard (p < 0.0001) and high-risk disease (p < 0.001). Grade 3 and 4 ototoxicity was seen in 7 of 75 (9.3%) and 9 of 91 (9.9%) ears (Brock, p = 0.91), 13 of 75 (17.3%) and 19 of 91 (20.9%) ears (POG, p = 0.56), and 15 of 75 (20.0%) and 21 of 91 (23.1%) ears (SIOP Boston, p = 0.63) with protons and photons respectively. CONCLUSIONS: While cochlear doses were lower in the proton group, patients treated with either protons or photons had similar Grade 3 and 4 ototoxicity rates.
|
Authors | Arnold C Paulino, Anita Mahajan, Rong Ye, David R Grosshans, M Fatih Okcu, Jack Su, Mary Frances McAleer, Susan McGovern, Victor A Mangona, Murali Chintagumpala |
Journal | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
(Radiother Oncol)
Vol. 128
Issue 1
Pg. 128-132
(07 2018)
ISSN: 1879-0887 [Electronic] Ireland |
PMID | 29373195
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Topics |
- Adolescent
- Audiometry, Pure-Tone
- Cerebellar Neoplasms
(radiotherapy)
- Child
- Child, Preschool
- Cochlea
(radiation effects)
- Female
- Hearing
(radiation effects)
- Hearing Loss
(prevention & control)
- Humans
- Male
- Medulloblastoma
(radiotherapy)
- Organ Sparing Treatments
(methods)
- Photons
(adverse effects, therapeutic use)
- Proton Therapy
(adverse effects)
- Radiation Dosage
- Radiation Tolerance
- Radiotherapy
(adverse effects, methods)
- Radiotherapy Dosage
|